Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

963
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
963
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.2K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Historical Review of Encircling Laser Retinopexy as a Prophylaxis for Rhegmatogenous Retinal Detachment; and a Commentary on Recent Progress in Stickler Syndrome.

Clinical ophthalmology (Auckland, N.Z.)·2026
Same author

Management of traumatic corneal wounds that do not seal after primary closure: a systematic review.

Eye (London, England)·2026
Same author

RE: Camp DA, Bakhsh SR, Torkashvand A, et al. Laser prophylaxis for retinal detachment in Stickler syndrome: A systematic review and meta-analysis. Acta Ophthalmologica. 2025 May 15. doi: 10.1111/aos.17509. Epub ahead of print. PMID: 40370211.

Acta ophthalmologica·2026
Same author

Subacute Terson Syndrome in a Patient With Monocular Vision After Craniofacial Ballistic Injury.

Journal of vitreoretinal diseases·2026
Same author

Use of preoperative imaging in open globe injury management: a systematic review.

The British journal of ophthalmology·2025
Same author

Can Laser Retinopexy Prevent Retinal Detachment in Asymptomatic, High-Risk Eyes?

Clinical ophthalmology (Auckland, N.Z.)·2025

Related Experiment Video

Updated: Jan 18, 2026

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

4.3K

Vitrectomy as a Prevention for Retinal Detachment in High-Risk Eyes.

Robert E Morris1,2,3, Ferenc Kuhn1,4, Mathew R Sapp1,2,3

  • 1Helen Keller Eye Research Foundation, Birmingham, AL, USA.

Clinical Ophthalmology (Auckland, N.Z.)
|September 10, 2025
PubMed
Summary

Rhegmatogenous retinal detachment (RD) is a common cause of vision loss. Peripheral laser retinopexy and vitrectomy can reduce vitreous traction, offering enhanced prophylaxis against RD in high-risk eyes.

Keywords:
encircling laser prophylaxisiatrogenic retinal tearsretinal detachmentretinal detachment preventionvitrectomy prophylaxis

More Related Videos

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats
04:16

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats

Published on: March 7, 2025

976
Retinal Detachment Model in Rodents by Subretinal Injection of Sodium Hyaluronate
05:58

Retinal Detachment Model in Rodents by Subretinal Injection of Sodium Hyaluronate

Published on: September 11, 2013

21.4K

Related Experiment Videos

Last Updated: Jan 18, 2026

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

4.3K
Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats
04:16

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats

Published on: March 7, 2025

976
Retinal Detachment Model in Rodents by Subretinal Injection of Sodium Hyaluronate
05:58

Retinal Detachment Model in Rodents by Subretinal Injection of Sodium Hyaluronate

Published on: September 11, 2013

21.4K

Area of Science:

  • Ophthalmology
  • Retinal Diseases
  • Surgical Innovation

Background:

  • Rhegmatogenous retinal detachment (RD) is the primary cause of sudden vision loss in aging individuals.
  • Retinal breaks, often peripheral tears, result from vitreous traction during posterior vitreous detachment.
  • Current prophylactic measures include peripheral encircling laser retinopexy for high-risk eyes.

Purpose of the Study:

  • To evaluate advanced vitrectomy techniques for reducing vitreous traction in high-risk eyes.
  • To explore maximal lifetime prophylaxis strategies for preventing retinal detachment.
  • To investigate the combined efficacy of laser retinopexy and vitrectomy.

Main Methods:

  • Review of advanced vitrectomy techniques for vitreous removal.
  • Application of peripheral encircling laser retinopexy in selected high-risk cases.
  • Analysis of the reduction in vitreous traction post-intervention.

Main Results:

  • Peripheral laser retinopexy enhances retinal resistance to vitreous traction.
  • Advanced vitrectomy effectively removes vitreous, further reducing traction.
  • Combined approach offers maximal lifetime prophylaxis in high-risk eyes.

Conclusions:

  • A combined strategy of laser retinopexy and vitrectomy provides robust prophylaxis against RD.
  • Vitrectomy is a viable option to reduce vitreous traction after laser retinopexy.
  • This approach offers a pathway to maximal lifetime prevention of vision loss from RD.